ro glp 1 supply tracker Ro's Helps Patients Locate In-Demand GLP-1 Drugs Amid Shortages ro glp 1 Ro launches

Summary Foundayo is a GLP-1 receptor agonist, placing it in the same drug class as Ozempic, Wegovy, and Mounjaro, but its small-molecule structure allows it to function as a once-daily pill rather than a weekly injection

Funding This study was sponsored by Novo Nordisk A/S

The criteria for both Mounjaro and Wegovy are: BMI of 30 or above, or BMI of 27 or above with at least one weight-related health condition (such as type 2 diabetes, high blood pressure, or obstructive sleep apnoea) If your BMI is below 27, you wont currently be eligible for GLP-1 medication for weight management through the NHS or private prescribers in the UK 7,8

Let your provider know if you have any questions about the injection process

J., Wenger, N., Esposito, M

The gap between the 12% of Americans who have tried GLP-1 medications and the 37% who are obese suggests that millions have been waiting for a format that fits their actual lives